ZYXI(Delisted)
Zynex·NASDAQ
--
--(--)
ZYXI fundamentals
Zynex (ZYXI) released its earnings on Nov 17, 2025: revenue was 13.36M (YoY -73.28%), missed estimates; EPS was -1.42 (YoY -2128.57%), missed estimates.
Revenue / YoY
13.36M
-73.28%
EPS / YoY
-1.42
-2128.57%
Report date
Nov 17, 2025
ZYXI Earnings Call Summary for Q3,2025
- Revenue Collapse: Q3 2025 revenue plummeted 73% to $13.4M due to TRICARE suspension and workforce cuts.
- Critical Debt Risk: $60M convertible notes maturing May 2026; missed $1.5M interest payment, entering 30-day grace period.
- Massive Impairment Charge: $30.7M writedown for Zynex Monitoring Solutions assets.
- Strategic Shifts: Implemented patient confirmation resupply policy; expanded VA partnerships to stabilize orders.
- Cash Burn: Reduced to $6.3M in Q3, but only $13.3M cash on hand as of September 30.
EPS
Revenue
Revenue & Expenses
ZYXI has released its 2025 Q3 earnings report, with revenue of 13.36M, reflecting a YoY change of -73.26%, and net profit of -42.91M, showing a YoY change of -1901.60%. The Sankey diagram below clearly presents ZYXI's revenue sources and cost distribution.
Key Indicators
Zynex (ZYXI) key financial stats and ratios, covering profitability, financial health, and leverage.
Zynex (ZYXI)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Zynex (ZYXI)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Zynex (ZYXI)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Zynex (ZYXI) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Zynex (ZYXI) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
No Data
